Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05519215 · ClinicalTrials.gov registry record

A Study of ECHELON 3000 (Next Generation Powered Stapler) in General Abdominal and Thoracic Lung Resection Procedures

A clinical trial of Laparoscopic Sleeve Gastrectomy (LSG) and Thoracic Lung Resection Procedure, sponsored by Ethicon Endo-Surgery.

Completed
Registry status
244
Enrollment target
8
Study locations

NCT05519215 is a study of Laparoscopic Sleeve Gastrectomy (LSG) and Thoracic Lung Resection Procedure that has completed, run by Ethicon Endo-Surgery. The registered enrollment target is 244 participants. The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05519215, a study of Laparoscopic Sleeve Gastrectomy (LSG) and Thoracic Lung Resection Procedure, has completed, sponsored by Ethicon Endo-Surgery.

COMPLETED
Registry status
244 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to assess the safety and performance of the ECHELON 3000 Stapler (next generation powered stapler) and reload system in participants undergoing laparoscopic sleeve gastrectomy or lung resection procedures (Video-Assisted Thoracoscopic \[ATS\] or open approach).

Interventions

  • DEVICE ECHELON 3000 Stapler

Study Locations (8)

Michigan

  • Henry Ford Health Center - Detroit
  • Ascension Providence Hospital - Southfield

California

  • Cedars-Sinai Medical Center - Los Angeles

District of Columbia

  • George Washington University Hospital - Washington D.C.

Georgia

  • Emory Cardiothoracic Surgery - Atlanta

Minnesota

  • Mayo Clinic - Rochester

New York

  • Long Island Jewish Medical Center - New Hyde Park

Texas

  • Bariatric Medical Institute of Texas - San Antonio

Trial Details

FieldValue
Enrollment Target 244 participants
Start Date 2023-03-22
Est. Completion 2025-01-08

Sponsor

Ethicon Endo-Surgery

39 total trials

What the Registry Record Tells You About NCT05519215

The ClinicalTrials.gov registry entry for NCT05519215 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon Endo-Surgery, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Laparoscopic Sleeve Gastrectomy (LSG) appearing as the primary indexed condition, and to 1 intervention - of which ECHELON 3000 Stapler is the first listed.

NCT05519215 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Michigan, California, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05519215 about?

NCT05519215 is a clinical study titled "A Study of ECHELON 3000 (Next Generation Powered Stapler) in General Abdominal and Thoracic Lung Resection Procedures". The purpose of this study is to assess the safety and performance of the ECHELON 3000 Stapler (next generation powered stapler) and reload system in participants undergoing laparoscopic sleeve gastrectomy or lung resection procedures (Video-Assisted Thoracoscopic \[ATS\] or open approach).

What is the current status of trial NCT05519215?

This trial is currently completed. The enrollment target is 244 participants. The study started on 2023-03-22. Estimated completion is 2025-01-08.

What conditions does trial NCT05519215 study?

This clinical trial studies the following conditions: Laparoscopic Sleeve Gastrectomy (LSG), Thoracic Lung Resection Procedure.

What interventions are being tested in trial NCT05519215?

The interventions under investigation include: ECHELON 3000 Stapler (DEVICE).

Who is sponsoring clinical trial NCT05519215?

This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05519215 being conducted?

This trial has 8 study locations across California, District of Columbia, Georgia, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.